Ranbaxy Strengthens Ties With Injectables Specialist Zenotech
This article was originally published in The Pink Sheet Daily
Executive Summary
Expanded investment will help Ranbaxy’s position in the specialty sector, firm says; the two Indian companies have already collaborated on development of a biosimilar.